Sign in

CIK 0001326732 · Accelerated filer

Ticker
XNCR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
201622502
Phone
626-305-5900
Business address
465 N. HALSTEAD ST., SUITE 200, PASADENA, CA, 91107
  1. SCHEDULE 13G Stake Statement of Beneficial Ownership
  2. 4 Open-market sale SR. VICE PRESIDENT & CFO sold 10,100 shares at $39.82 ($402,182)
  3. 4 Open-market sale Director sold 81,252 shares at an average $39.25 ($3,189,435)
  4. 144 Insider Sale of Securities
  5. 144 Insider Sale of Securities
  6. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  7. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. 8-K Event Results of operations
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Results of operations · Regulation FD disclosure · Other events
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. 8-K Event Material agreement · Results of operations · Regulation FD disclosure
  17. 4 Grant or award Director acquired 10,302 shares (grant or award)
  18. 4 Grant or award Director acquired 10,302 shares (grant or award)
  19. 4 Grant or award Director acquired 10,302 shares (grant or award)
  20. 4 Grant or award Director acquired 10,302 shares (grant or award)

Page 1 of 46 · 902 filings